HER2 amplification through CISH -chromogenic hybridization in situ- on breast cancer Her 2 2+by immunohistochemistry -ICH

被引：0
|
作者：
Bella, S. R. [1 ]
Lerda, D. [1 ]
Guidi, A. [1 ]
Theaux, R. [1 ]
Armando, L. [1 ]
Sambuelli, R. [1 ]
机构：
[1] Catholic Univ, Univ Clin R Fabiola, Cordoba, Argentina
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.22147
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22147
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HER 2 protein overexpression and gene amplification in breast cancer:: A comparison of immunohistochemistry and fluorescent and chromogenic in situ hybridization
    Sáez, A
    Andreu, F
    Fernández, S
    Seguí, M
    Rey, M
    LABORATORY INVESTIGATION, 2005, 85 : 49A - 49A
  • [32] Evaluation of Dual Immunohistochemistry and Chromogenic In Situ Hybridization for HER2 on a Single Section
    Reisenbichler, Emily S.
    Horton, Debra
    Rasco, Marva
    Andea, Aleodor
    Hameed, Omar
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (01) : 102 - 110
  • [33] Characterisation of HER2 Status in DCIS Using Immunohistochemistry (IHC) and Chromogenic in situ Hybridisation (CISH)
    Miligy, I.
    Gaber, A.
    Toss, M. S.
    Al-Kawaz, A. A.
    Nolan, C. C.
    Diez-Rodriguez, M. A.
    Burrell, H.
    Ellis, I. O.
    Green, A. R.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2018, 245 : S5 - S5
  • [34] Detection of HER-2 gene amplification using chromogenic in situ hybridization (CISH) and tissue microarray: Correlation with HER2 protein expression using inummohistochemistry
    Askeland, RW
    Vasef, MA
    LABORATORY INVESTIGATION, 2003, 83 (01) : 318A - 319A
  • [35] Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
    L Arnould
    Y Denoux
    G MacGrogan
    F Penault-Llorca
    M Fiche
    I Treilleux
    M C Mathieu
    A Vincent-Salomon
    M O Vilain
    J Couturier
    British Journal of Cancer, 2003, 88 : 1587 - 1591
  • [36] Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
    Yano, T
    Doi, T
    Ohtsu, A
    Boku, N
    Hashizume, K
    Nakanishi, M
    Ochiai, A
    ONCOLOGY REPORTS, 2006, 15 (01) : 65 - 71
  • [37] Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
    Arnould, L
    Denoux, Y
    MacGrogan, G
    Penault-Llorca, F
    Fiche, M
    Treilleux, I
    Mathieu, MC
    Vincent-Salomon, A
    Vilain, MO
    Couturier, J
    BRITISH JOURNAL OF CANCER, 2003, 88 (10) : 1587 - 1591
  • [38] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Nie, Xiu
    He, Jun
    Li, Yan
    Pan, Dan-zhen
    Pan, Hua-xiong
    Weng, Mi-xia
    Yang, Xiu-ping
    Liu, Chun-ping
    Huang, Tao
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (03) : 379 - 384
  • [39] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Xiu Nie
    Jun He
    Yan Li
    Dan-zhen Pan
    Hua-xiong Pan
    Mi-xia Weng
    Xiu-ping Yang
    Chun-ping Liu
    Tao Huang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 379 - 384
  • [40] Accurate Assessment of HER2 Gene Status for Invasive Component of Breast Cancer by Combination of Immunohistochemistry and Chromogenic In Situ Hybridization
    聂秀
    贺骏
    李燕
    潘丹珍
    潘华雄
    翁密霞
    杨秀萍
    刘春萍
    黄韬
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2013, 33 (03) : 379 - 384
12345